Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.

Noubade R, Majri-Morrison S, Tarbell KV.

Front Immunol. 2019 May 9;10:1014. doi: 10.3389/fimmu.2019.01014. eCollection 2019. Review.

2.

Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.

Arenzana TL, Lianoglou S, Seki A, Eidenschenk C, Cheung T, Seshasayee D, Hagenbeek T, Sambandam A, Noubade R, Peng I, Lesch J, DeVoss J, Wu X, Lee WP, Caplazi P, Webster J, Liu J, Pham VC, Arnott D, Lill JR, Modrusan Z, Dey A, Rutz S.

Sci Immunol. 2018 Apr 20;3(22). pii: eaal1953. doi: 10.1126/sciimmunol.aal1953.

PMID:
29678836
3.

Mice deficient in NRROS show abnormal microglial development and neurological disorders.

Wong K, Noubade R, Manzanillo P, Ota N, Foreman O, Hackney JA, Friedman BA, Pappu R, Scearce-Levie K, Ouyang W.

Nat Immunol. 2017 Jun;18(6):633-641. doi: 10.1038/ni.3743. Epub 2017 May 1.

PMID:
28459434
4.

NeuCode Proteomics Reveals Bap1 Regulation of Metabolism.

Baughman JM, Rose CM, Kolumam G, Webster JD, Wilkerson EM, Merrill AE, Rhoads TW, Noubade R, Katavolos P, Lesch J, Stapleton DS, Rabaglia ME, Schueler KL, Asuncion R, Domeyer M, Zavala-Solorio J, Reich M, DeVoss J, Keller MP, Attie AD, Hebert AS, Westphall MS, Coon JJ, Kirkpatrick DS, Dey A.

Cell Rep. 2016 Jul 12;16(2):583-595. doi: 10.1016/j.celrep.2016.05.096. Epub 2016 Jun 30.

5.

Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells.

Rutz S, Kayagaki N, Phung QT, Eidenschenk C, Noubade R, Wang X, Lesch J, Lu R, Newton K, Huang OW, Cochran AG, Vasser M, Fauber BP, DeVoss J, Webster J, Diehl L, Modrusan Z, Kirkpatrick DS, Lill JR, Ouyang W, Dixit VM.

Nature. 2015 Feb 19;518(7539):417-21. doi: 10.1038/nature13979. Epub 2014 Dec 3.

PMID:
25470037
6.

NRROS negatively regulates reactive oxygen species during host defence and autoimmunity.

Noubade R, Wong K, Ota N, Rutz S, Eidenschenk C, Valdez PA, Ding J, Peng I, Sebrell A, Caplazi P, DeVoss J, Soriano RH, Sai T, Lu R, Modrusan Z, Hackney J, Ouyang W.

Nature. 2014 May 8;509(7499):235-9. doi: 10.1038/nature13152. Epub 2014 Apr 13.

PMID:
24739962
7.

A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3.

Murthy A, Li Y, Peng I, Reichelt M, Katakam AK, Noubade R, Roose-Girma M, DeVoss J, Diehl L, Graham RR, van Lookeren Campagne M.

Nature. 2014 Feb 27;506(7489):456-62. doi: 10.1038/nature13044. Epub 2014 Feb 19.

PMID:
24553140
8.

G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization.

Diehl SA, McElvany B, Noubade R, Seeberger N, Harding B, Spach K, Teuscher C.

Infect Immun. 2014 Feb;82(2):773-82. doi: 10.1128/IAI.00971-13. Epub 2013 Dec 9.

9.

Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells.

Krementsov DN, Noubade R, Dragon JA, Otsu K, Rincon M, Teuscher C.

Ann Neurol. 2014 Jan;75(1):50-66. doi: 10.1002/ana.24020.

10.

Histamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.

Krementsov DN, Wall EH, Martin RA, Subramanian M, Noubade R, Del Rio R, Mawe GM, Bond JP, Poynter ME, Blankenhorn EP, Teuscher C.

PLoS One. 2013 Jul 22;8(7):e62743. doi: 10.1371/journal.pone.0062743. Print 2013.

11.

Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.

Saligrama N, Case LK, del Rio R, Noubade R, Teuscher C.

J Immunol. 2013 Jul 15;191(2):614-22. doi: 10.4049/jimmunol.1203137. Epub 2013 Jun 14.

12.

H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis.

Saligrama N, Noubade R, Case LK, Poynter ME, Teuscher C.

Cell Immunol. 2012 Jul-Aug;278(1-2):27-34. doi: 10.1016/j.cellimm.2012.06.012. Epub 2012 Jul 14.

13.

Loss of the tumor suppressor BAP1 causes myeloid transformation.

Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, Kirkpatrick DS, Pham VC, Lill JR, Bakalarski CE, Wu J, Phu L, Katavolos P, LaFave LM, Abdel-Wahab O, Modrusan Z, Seshagiri S, Dong K, Lin Z, Balazs M, Suriben R, Newton K, Hymowitz S, Garcia-Manero G, Martin F, Levine RL, Dixit VM.

Science. 2012 Sep 21;337(6101):1541-6. Epub 2012 Aug 9.

14.

Combinatorial roles for histamine H1-H2 and H3-H4 receptors in autoimmune inflammatory disease of the central nervous system.

Saligrama N, Noubade R, Case LK, del Rio R, Teuscher C.

Eur J Immunol. 2012 Jun;42(6):1536-46. doi: 10.1002/eji.201141859.

15.

Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.

del Rio R, Noubade R, Saligrama N, Wall EH, Krementsov DN, Poynter ME, Zachary JF, Thurmond RL, Teuscher C.

J Immunol. 2012 Jan 15;188(2):541-7. doi: 10.4049/jimmunol.1101498. Epub 2011 Dec 5.

16.

Histamine H(1) receptor signaling regulates effector T cell responses and susceptibility to coxsackievirus B3-induced myocarditis.

Case LK, Moussawi M, Roberts B, Noubade R, Huber SA, Teuscher C.

Cell Immunol. 2012;272(2):269-74. doi: 10.1016/j.cellimm.2011.10.004. Epub 2011 Oct 15.

17.

Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17 cells.

Rutz S, Noubade R, Eidenschenk C, Ota N, Zeng W, Zheng Y, Hackney J, Ding J, Singh H, Ouyang W.

Nat Immunol. 2011 Oct 16;12(12):1238-45. doi: 10.1038/ni.2134.

PMID:
22001828
18.

Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis.

Noubade R, Krementsov DN, Del Rio R, Thornton T, Nagaleekar V, Saligrama N, Spitzack A, Spach K, Sabio G, Davis RJ, Rincon M, Teuscher C.

Blood. 2011 Sep 22;118(12):3290-300. doi: 10.1182/blood-2011-02-336552. Epub 2011 Jul 25.

19.

Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis.

Lu C, Diehl SA, Noubade R, Ledoux J, Nelson MT, Spach K, Zachary JF, Blankenhorn EP, Teuscher C.

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18967-72. doi: 10.1073/pnas.1008816107. Epub 2010 Oct 18.

20.

Multiple linked quantitative trait loci within the Tmevd2/Eae3 interval control the severity of experimental allergic encephalomyelitis in DBA/2J mice.

Spach KM, Case LK, Noubade R, Petersen CB, McElvany B, Zalik N, Hickey WF, Blankenhorn EP, Teuscher C.

Genes Immun. 2010 Dec;11(8):649-59. doi: 10.1038/gene.2010.40. Epub 2010 Sep 23.

21.

A single nucleotide polymorphism in Tyk2 controls susceptibility to experimental allergic encephalomyelitis.

Spach KM, Noubade R, McElvany B, Hickey WF, Blankenhorn EP, Teuscher C.

J Immunol. 2009 Jun 15;182(12):7776-83. doi: 10.4049/jimmunol.0900142.

22.

Cutting edge: the Y chromosome controls the age-dependent experimental allergic encephalomyelitis sexual dimorphism in SJL/J mice.

Spach KM, Blake M, Bunn JY, McElvany B, Noubade R, Blankenhorn EP, Teuscher C.

J Immunol. 2009 Feb 15;182(4):1789-93. doi: 10.4049/jimmunol.0803200.

23.

The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells.

Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D, Noubade R, Briso EM, Charland C, Leonard WJ, Ciliberto G, Teuscher C, Haynes L, Rincon M.

J Exp Med. 2009 Jan 16;206(1):69-78. doi: 10.1084/jem.20081571. Epub 2009 Jan 12.

24.

von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.

Noubade R, del Rio R, McElvany B, Zachary JF, Millward JM, Wagner DD, Offner H, Blankenhorn EP, Teuscher C.

Am J Pathol. 2008 Sep;173(3):892-900. doi: 10.2353/ajpath.2008.080001. Epub 2008 Aug 7.

25.

Pertussis toxin induces angiogenesis in brain microvascular endothelial cells.

Lu C, Pelech S, Zhang H, Bond J, Spach K, Noubade R, Blankenhorn EP, Teuscher C.

J Neurosci Res. 2008 Sep;86(12):2624-40. doi: 10.1002/jnr.21716.

PMID:
18500752
26.

Autoimmune disease-associated histamine receptor H1 alleles exhibit differential protein trafficking and cell surface expression.

Noubade R, Saligrama N, Spach K, Del Rio R, Blankenhorn EP, Kantidakis T, Milligan G, Rincon M, Teuscher C.

J Immunol. 2008 Jun 1;180(11):7471-9. Erratum in: J Immunol. 2008 Oct 1;181(7):5174.

27.

SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3.

del Rio R, Noubade R, Subramanian M, Saligrama N, Diehl S, Rincon M, Teuscher C.

Genes Immun. 2008 Mar;9(2):115-21. doi: 10.1038/sj.gene.6364455. Epub 2008 Jan 17.

PMID:
18200031
28.

Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice.

Noubade R, Milligan G, Zachary JF, Blankenhorn EP, del Rio R, Rincon M, Teuscher C.

J Clin Invest. 2007 Nov;117(11):3507-18.

29.

Differentiation of pathogenic and saprophytic leptospires by polymerase chain reaction.

Noubade R, Krishnamurthy GV, Murag S, Venkatesha MD, Krishnappa G.

Indian J Med Microbiol. 2002 Jan-Mar;20(1):33-6.

30.

Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS.

Teuscher C, Subramanian M, Noubade R, Gao JF, Offner H, Zachary JF, Blankenhorn EP.

Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10146-51. Epub 2007 Jun 4.

31.

Evidence that the Y chromosome influences autoimmune disease in male and female mice.

Teuscher C, Noubade R, Spach K, McElvany B, Bunn JY, Fillmore PD, Zachary JF, Blankenhorn EP.

Proc Natl Acad Sci U S A. 2006 May 23;103(21):8024-9. Epub 2006 May 15.

Supplemental Content

Loading ...
Support Center